Moolec Science (MLEC) Short-term Investments (2022 - 2025)
Moolec Science's (MLEC) quarterly Short-term Investments came in at $8.3 million in Q2 2025, down 43.72% year-on-year from $14.7 million in Q2 2024, and up 179.32% quarter-over-quarter from -$10.4 million in Q4 2024.
Moolec Science (MLEC) Short-term Investments (2022 - 2025) Analysis & Trends
Moolec Science has disclosed Short-term Investments across 4 years of filings, most recently posting $8.3 million for Q2 2025.
- Short-term Investments for Q2 2025 came in at $8.3 million, down 43.72% year-over-year; the trailing twelve-month figure through Jun 2025 was $8.3 million (down 43.72% YoY), and the FY2025 annual result was $8.3 million, up 112.59% from the prior year.
- Short-term Investments came in at $8.3 million for Q2 2025 at Moolec Science, up from -$10.4 million in the prior quarter.
- In the past five years, Short-term Investments ranged from a high of $14.7 million in Q2 2024 to a low of -$10.4 million in Q4 2024.
- The 4-year median for Short-term Investments is $263.0 (2023), against an average of $771323.4.
- Peak annual rise in Short-term Investments reached 4692.8% in 2024, while the deepest fall reached 93.89% in 2024.
- Moolec Science's Short-term Investments stood at -$2.1 million in 2022, then tumbled by 161.06% to -$5.4 million in 2023, then tumbled by 93.89% to -$10.4 million in 2024, then jumped by 179.32% to $8.3 million in 2025.
- The last three Short-term Investments figures came in at $8.3 million (Q2 2025), -$10.4 million (Q4 2024), and $14.7 million (Q2 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - |
| 10 | Moolec Science | 6.98 Bn | 6.98 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 8.25 Mn |
| Dec 31, 2024 | -10.41 Mn |
| Jun 30, 2024 | 14.67 Mn |
| Dec 31, 2023 | -5.37 Mn |
| Sep 30, 2023 | 263.00 |
| Jun 30, 2023 | 306,034.00 |
| Jun 30, 2022 | -2.06 Mn |